NEW YORK, June 11, 2018 /PRNewswire/ -- Immunoglobulins, Albumins, Clotting Factors, Hyperimmune Globulins, Alpha 1 Antitrypsin Inhibitors (A1PI), C1 Esterase Inhibitors, Primary Immune Deficiency (PID), Secondary Immune Deficiency (SID), Idiopathic Thrombocytopenic Purpura (ITP), Cardiac & Surgery, Emergency Medicine, Haemophilia
Read the full report: https://www.reportlinker.com/p05437172
Report Details
In 2017, the global plasma fractionation market was valued at $24bn and is expected to grow at a CAGR of 9.0% in the first half of the forecast period. In 2017, the immunoglobulins submarket held 44.0% of the global plasma fractionation market. How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 172-page report you will receive 91 tables and 98 figures' all unavailable elsewhere. The 172-page report provides clear detailed insight into the global plasma fractionation market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope - Global Plasma Fractionation market forecasts from 2018-2028 - This report also breaks down the revenue forecast for the global plasma fractionation market by type of product: - Immunoglobulins - Albumins - Clotting Factors - Hyperimmune Globulins - Alpha 1 Antitrypsin Inhibitors (A1PI) - C-1 - Others - This report also breaks down the revenue forecast for the global plasma fractionation market by type of application: - Primary Immune Deficiency (PID) - Secondary Immune Deficiency (SID) - Idiopathic Thrombocytopenic Purpura (ITP) - Cardiac & Surgery - Emergency Medicine - Haemophilia - This report also breaks down the revenue forecast for the global plasma fractionation market by regional market: - North America - Europe - Latin America - Asia-Pacific - Middle East & Africa - This report also breaks down the revenue forecast for the global plasma fractionation market by national market: - US - Canada - UK - Germany - France - Spain - Italy - Rest of Europe - Japan - Rest of APAC - Our study discusses the selected leading companies that are the major players in the plasma fractionation industry: - Biotest - CSL - Grifols - Kedrion - LFB - OctaPharma - Shire/Baxalta - Others - Our study gives qualitative analysis of the plasma fractionation market. It discusses factors that drive and restrain the market - Other information included in this report: - Type of plasma processed in Europe from 1996 ' 2012 (3-year increment) for non-profit organizations (source plasma vs recovered plasma, in thousand liters) - Type of plasma processed in Europe from 1996 ' 2012 (3-year increment) for commercial companies (source plasma vs recovered plasma, in thousand liters) - Cost of plasma protein in Canada by product - Canadian plasma shipments for fractionation by source - Immunoglobulin-monthly distribution and 12-month rolling average distribution (2016/2017) for: the US, the UK, Germany, Italy, Spain, Austria, Finland, Greece, Norway, Portugal, Sweden, Switzerland - Albumin 5%-monthly distribution and 12-month rolling average distribution (2016/2017) for the US Read the full report: https://www.reportlinker.com/p05437172
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/global-plasma-fractionation-market-2018-2028-300664211.html
SOURCE Reportlinker
